1246956-18-2: Nepafenac Inhouse Impurity E

Status: In-stock

Nepafenac Impurity E (CAS No: 1246956-18-2) is an impurity present in Nepafenac which is a nonsteroidal anti-inflammatory drug that is used to treat a patient with chronic cystoid macular edema and after cataract removal and intraocular lens implantation in the left eye.

Additional information on CAS 1246956-18-2

Catalogue No. VL360001
CAS No. 1246956-18-2
Molecular Formula C₁₅H₁₆N₂O₂
Molecular Weight 256.3
Parent drug Nepafenac
IUPAC Name 2-Amino-3-(hydroxyphenylmethyl)-benzeneacetamide
Synonyms Nepafenac Hydroxybenzyl Impurity
References Lipiec-Abramska, El?bieta, et al. “Development and Validation of High Performance Liquid Chromatography with a Spectrophotometric Detection Method for the Chemical Purity and Assay of Nepafenac.” Journal of Pharmaceutical and Biomedical Analysis, vol. 91, Mar. 2014, pp. 1–6, https://doi.org/10.1016/j.jpba.2013.12.009.?Di Pascuale, Mario A., et al. “Corneal Melting after Use of Nepafenac in a Patient with Chronic Cystoid Macular Edema after Cataract Surgery.” Eye & Contact Lens: Science & Clinical
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1246956-18-2: Nepafenac Inhouse Impurity E

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.